![Michael James Mullen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael James Mullen
Investitore di Private Equity presso
C5 Capital Ltd.
Profilo
Mr. Michael J.
Mullen, CPA, is Independent Director at Alseres Pharmaceuticals, Inc. He is on the Board of Directors at Alseres Pharmaceuticals, Inc.
Mr. Mullen was previously employed as Chief Financial Officer by Rapid Micro Biosystems, Inc., Chief Financial Officer by Magellan Biosciences Point-Of-Care, Inc., Chief Financial Officer by JMH Capital LLC, Chief Financial Officer by Magellan Discovery Technologies LLC, Chief Financial Officer by PerkinElmer, Inc., Chief Financial Officer & Controller by Thermo Optek Corp., Chief Financial Officer by Valeritas, Inc., and a Principal by Arthur Andersen LLP.
He received his undergraduate degree from James Madison University.
Posizioni attive di Michael James Mullen
| Società | Posizione | Inizio |
|---|---|---|
C5 Capital Ltd.
 C5 Capital Ltd. Investment ManagersFinance C5 Capital invests in companies located across the globe. The firm focuses on companies operating in the fields of cybersecurity, space, and nuclear energy. It participates in early and later stage capital requirements. | Investitore di Private Equity | - |
Precedenti posizioni note di Michael James Mullen
| Società | Posizione | Fine |
|---|---|---|
Magellan Diagnostics, Inc.
 Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic laboratory products | Direttore Finanziario/CFO | 01/10/2009 |
JMH Capital LLC
 JMH Capital LLC Investment ManagersFinance JMH Capital invests in lower middle-market companies located in the United States with an EBITDA of USD 1 - 10 million and revenues of USD 5 - 100 million. The firm focuses on companies operating across a broad range of sectors. It participates in recapitalizations, MBOs, corporate carve-outs, and buyout transactions with a transaction size of up to USD 30 million. It makes investments with limited partners and acts as a co-investor. | Fondatore | 01/03/2006 |
Magellan Discovery Technologies LLC | Direttore Finanziario/CFO | 01/12/2002 |
| REVVITY, INC. | Direttore Finanziario/CFO | 01/09/2000 |
Thermo Optek Corp.
 Thermo Optek Corp. Medical SpecialtiesHealth Technology Makes analytical and environmental monitoring instruments | Direttore Finanziario/CFO | 01/03/1999 |
Formazione di Michael James Mullen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
35
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Alseres Pharmaceuticals, Inc.
 Alseres Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and diagnostic products | Health Technology |
Thermo Optek Corp.
Thermo Optek Corp. Medical SpecialtiesHealth Technology Makes analytical and environmental monitoring instruments | Health Technology |
Revvity, Inc.
 Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Rapid Micro Biosystems, Inc.
 Rapid Micro Biosystems, Inc. Industrial MachineryProducer Manufacturing Develops automation solutions for pharmaceutical and healthcare manufacturing products | Producer Manufacturing |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Magellan Diagnostics, Inc.
Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic laboratory products | Health Technology |
James Madison University
 James Madison University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JMH Capital LLC
JMH Capital LLC Investment ManagersFinance JMH Capital invests in lower middle-market companies located in the United States with an EBITDA of USD 1 - 10 million and revenues of USD 5 - 100 million. The firm focuses on companies operating across a broad range of sectors. It participates in recapitalizations, MBOs, corporate carve-outs, and buyout transactions with a transaction size of up to USD 30 million. It makes investments with limited partners and acts as a co-investor. | Finance |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
Magellan Discovery Technologies LLC | |
C5 Capital Ltd.
C5 Capital Ltd. Investment ManagersFinance C5 Capital invests in companies located across the globe. The firm focuses on companies operating in the fields of cybersecurity, space, and nuclear energy. It participates in early and later stage capital requirements. | Finance |
